Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5172463
Max Phase: Preclinical
Molecular Formula: C24H26O8
Molecular Weight: 442.46
Associated Items:
ID: ALA5172463
Max Phase: Preclinical
Molecular Formula: C24H26O8
Molecular Weight: 442.46
Associated Items:
Canonical SMILES: COC(=O)/C=C(/CC1=C(CCC(=O)CC2(C)OCCO2)C(=O)c2ccccc2C1=O)OC
Standard InChI: InChI=1S/C24H26O8/c1-24(31-10-11-32-24)14-15(25)8-9-19-20(12-16(29-2)13-21(26)30-3)23(28)18-7-5-4-6-17(18)22(19)27/h4-7,13H,8-12,14H2,1-3H3/b16-13-
Standard InChI Key: BCOULIQWVANRPO-SSZFMOIBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 442.46 | Molecular Weight (Monoisotopic): 442.1628 | AlogP: 2.96 | #Rotatable Bonds: 9 |
Polar Surface Area: 105.20 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.28 | CX LogD: 2.28 |
Aromatic Rings: 1 | Heavy Atoms: 32 | QED Weighted: 0.33 | Np Likeness Score: 0.76 |
1. Furqan M, Fayyaz A, Firdous F, Raza H, Bilal A, Saleem RSZ, Shahzad-Ul-Hussan S, Wang D, Youssef FS, Al Musayeib NM, Ashour ML, Hussain H, Faisal A.. (2022) Identification and Characterization of Natural and Semisynthetic Quinones as Aurora Kinase Inhibitors., 85 (6.0): [PMID:35687347] [10.1021/acs.jnatprod.1c01222] |
Source(1):